Assessing Treatment Outcomes for Intrabony Defects: Nanohydroxyapatite vs. Injectable Platelet-Rich Fibrin with or without Laser Therapy
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2024/01/061481
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
I. Patients of both sexes between 30 and 65 years of age with moderate
To severe generalized periodontitis.
Ii. Patients exhibiting atleast one intrabony defect with probing pocket
Depth = 5mm, radiographic defect on iopa of = 3mm and two or three
Walled defect in maxillary and mandibular posterior regions.
Iii. Patients exhibiting clinical attachment loss (cal) = 4 mm.
Iv. No history of intake of antibiotics or other medications affecting the
Periodontium in preceding 6 months.
V. Patient willing for surgery and ready to give written consent.
I. Systemic illness known to affect the outcomes of periodontal therapy
Ii. Smokers, pregnant/lactating patients & patients with malocclusion
Were excluded.
Iii. Teeth with endodontic (pulpal) involvement.
Iv. Patient on medication such as corticosteroids and calcium channel
Blockers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical and radiographic evaluation of nanohydroxyapatite bone graft and injectable platelet rich fibrin with or without diode laser therapy for treatment of intrabony defectsTimepoint: baseline to 6 months
- Secondary Outcome Measures
Name Time Method oneTimepoint: None